SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Long Term Provisions | ₹3.30 Cr | ₹2.69 Cr | ₹1.71 Cr | - | - |
What is the latest Long Term Provisions ratio of SYNCOM FORMULATIONS (INDIA) ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹3.30 Cr |
Mar2023 | ₹2.69 Cr |
Mar2022 | ₹1.71 Cr |
Mar2017 | - |
Mar2016 | - |
How is Long Term Provisions of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹3.30 Cr | 22.73 | |
Mar2023 | ₹2.69 Cr | 57.43 | |
Mar2022 | ₹1.71 Cr | 0 | |
Mar2017 | - | 0 | |
Mar2016 | - | - |
Compare Long Term Provisions of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹2,045.4 Cr | -2.7% | 8.4% | 95.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹432,948.0 Cr | -0% | 0.5% | 46.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,873.0 Cr | -3% | 0.9% | 61.2% | Stock Analytics | |
CIPLA | ₹116,809.0 Cr | -2.1% | -6.9% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,963.0 Cr | -0.6% | -3.3% | 7.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,173.2 Cr | -1.9% | 0.7% | 54.5% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | -2.7% |
8.4% |
95.3% |
SENSEX | -0.6% |
2.3% |
16.9% |
You may also like the below Video Courses